VitalCaring's AI-driven Cognitive Care Pilot:
Has shown impressive results, with patients experiencing significant cognitive improvements . The pilot program, which ran from October 2023 to May 2024, included 52 patients aged 54 to 92, with an average age of 77.45. Patients had various primary diagnoses, including cerebral infarction, brain tumors, dementia, Parkinson's disease, encephalitis, encephalopathy, and mild cognitive impairment (MCI).
Key Highlights:
35% increase in Montreal Cognitive Assessment (MoCA) average score.
33% increase in Saint Louis University Mental Status (SLUMS) average score.
55% of patients improved by at least one cognitive level.
35% of patients achieved normal cognitive functional score by discharge.
These results demonstrate the potential of AI-driven cognitive care to enhance personalized therapy for patients with cognitive disorders. By leveraging innovative tools like Constant Therapy's digital speech, language, and cognitive therapy platform, healthcare providers can extend exceptional care and support patient's journeys toward regaining independence safely in their homes .
SOURCE- Globenewswire
#AICognitiveCare #CognitiveHealth #PersonalizedTherapy #DigitalTherapy
#ArtificialIntelligenceInHealthcare #InnovationInHealthcare #CognitiveRehabilitation
#BrainHealth #Neuroplasticity #HealthTech #Caregiving #ElderlyCare
Has shown impressive results, with patients experiencing significant cognitive improvements . The pilot program, which ran from October 2023 to May 2024, included 52 patients aged 54 to 92, with an average age of 77.45. Patients had various primary diagnoses, including cerebral infarction, brain tumors, dementia, Parkinson's disease, encephalitis, encephalopathy, and mild cognitive impairment (MCI).
Key Highlights:
35% increase in Montreal Cognitive Assessment (MoCA) average score.
33% increase in Saint Louis University Mental Status (SLUMS) average score.
55% of patients improved by at least one cognitive level.
35% of patients achieved normal cognitive functional score by discharge.
These results demonstrate the potential of AI-driven cognitive care to enhance personalized therapy for patients with cognitive disorders. By leveraging innovative tools like Constant Therapy's digital speech, language, and cognitive therapy platform, healthcare providers can extend exceptional care and support patient's journeys toward regaining independence safely in their homes .
SOURCE- Globenewswire
#AICognitiveCare #CognitiveHealth #PersonalizedTherapy #DigitalTherapy
#ArtificialIntelligenceInHealthcare #InnovationInHealthcare #CognitiveRehabilitation
#BrainHealth #Neuroplasticity #HealthTech #Caregiving #ElderlyCare
VitalCaring's AI-driven Cognitive Care Pilot:
Has shown impressive results, with patients experiencing significant cognitive improvements . The pilot program, which ran from October 2023 to May 2024, included 52 patients aged 54 to 92, with an average age of 77.45. Patients had various primary diagnoses, including cerebral infarction, brain tumors, dementia, Parkinson's disease, encephalitis, encephalopathy, and mild cognitive impairment (MCI).
Key Highlights:
35% increase in Montreal Cognitive Assessment (MoCA) average score.
33% increase in Saint Louis University Mental Status (SLUMS) average score.
55% of patients improved by at least one cognitive level.
35% of patients achieved normal cognitive functional score by discharge.
These results demonstrate the potential of AI-driven cognitive care to enhance personalized therapy for patients with cognitive disorders. By leveraging innovative tools like Constant Therapy's digital speech, language, and cognitive therapy platform, healthcare providers can extend exceptional care and support patient's journeys toward regaining independence safely in their homes .
SOURCE- Globenewswire
#AICognitiveCare #CognitiveHealth #PersonalizedTherapy #DigitalTherapy
#ArtificialIntelligenceInHealthcare #InnovationInHealthcare #CognitiveRehabilitation
#BrainHealth #Neuroplasticity #HealthTech #Caregiving #ElderlyCare
